Conatus Pharmaceuticals Profit Margin 2012-2018 | CNAT
Current and historical gross margin, operating margin and net profit margin for Conatus Pharmaceuticals (CNAT) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Conatus Pharmaceuticals net profit margin as of December 31, 2018 is -53.62%.
|Conatus Pharmaceuticals Annual Profit Margins
|Conatus Pharmaceuticals Quarterly Profit Margins
||Medical Products Manufacturing
Conatus Pharmaceuticals, Inc. is a biotechnology company. It is focused on developing and commercializing medicines to treat liver disease. The Company is developing its lead compound, emricasan, for the treatment of patients in orphan populations with chronic liver disease and acute exacerbations of chronic liver disease. Conatus Pharmaceuticals, Inc. is headquartered in San Diego, California.